Investment analysts at StockNews.com began coverage on shares of Infinity Pharmaceuticals (NASDAQ:INFI – Get Free Report) in a research report issued to clients and investors on Monday. The firm set a “hold” rating on the biotechnology company’s stock. Infinity Pharmaceuticals Price Performance NASDAQ:INFI opened at $0.01 on Monday. The stock’s fifty day simple moving average […]
StockNews.com assumed coverage on shares of Infinity Pharmaceuticals (NASDAQ:INFI – Free Report) in a research note published on Sunday. The firm issued a hold rating on the biotechnology company’s stock. Infinity Pharmaceuticals Price Performance Infinity Pharmaceuticals has a twelve month low of $0.01 and a twelve month high of $0.01. The company has a market […]
StockNews.com started coverage on shares of Infinity Pharmaceuticals (NASDAQ:INFI – Free Report) in a research note published on Friday. The brokerage issued a hold rating on the biotechnology company’s stock. Infinity Pharmaceuticals Price Performance Shares of NASDAQ INFI opened at $0.01 on Friday. The firm has a market cap of $726,080.00, a P/E ratio of […]
Infinity Pharmaceuticals (NASDAQ:INFI) Now Covered by StockNews com themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Infinity Pharmaceuticals, Inc. (NASDAQ:INFI – Get Free Report) was the target of a significant increase in short interest in the month of August. As of August 15th, there was short interest totalling 1,970,000 shares, an increase of 114.4% from the July 31st total of 918,900 shares. Based on an average daily volume of 3,200,000 shares, […]